Lincomycin is an antibiotic that comes from the actinomycete Streptomyces lincolnensis. It belongs to the lincosamide class of antibiotics. It has the following indications:
-
- Lincomycin is effective against Gram-positive bacteria and cell wall-less bacteria, including pathogenic species of:
- Streptococcus
- Staphylococcus
- Mycoplasma
- It is used to treat severe bacterial infections in patients who cannot use penicillin antibiotics.
- Lincomycin is effective against Gram-positive bacteria and cell wall-less bacteria, including pathogenic species of:
- Administration:
- Lincomycin is available as a Capsule, Syrup and an injectable antibiotic.
- The capsule and syrup are usually taken every 6hours.
- It is a good option for people allergic to penicillin.
- Click HERE for similar products.
Related products
-
Fidson Cefuroxime 125mg/5ml Syrup
₦4,500.00Add to cart- Cefuroxime axetil for oral suspension contains cefuroxime as cefuroxime axetil. It is a semisynthetic, broad-spectrum cephalosporin antibiotic for oral administration
- Dosage: When reconstituted with water, it provides the equivalent of 125 mg or 250 mg of cefuroxime (as cefuroxime axetil) per 5 mL of suspension.
-
Nonispa (Cefuroxime 125mg/5ml) Susp
₦6,700.00Add to cart- Description: Cefuroxime axetil for oral suspension contains cefuroxime as cefuroxime axetil. It is a semisynthetic, broad-spectrum cephalosporin antibiotic for oral administration
- Dosage: When reconstituted with water, it provides the equivalent of 125 mg or 250 mg of cefuroxime (as cefuroxime axetil) per 5 mL of suspension.
-
Staxim (Cefuroxime 125mg/5ml) Suspension
₦5,000.00Add to cartCefuroxime axetil for oral suspension contains cefuroxime as cefuroxime axetil. It is a semisynthetic, broad-spectrum cephalosporin antibiotic for oral administration.
-
Primpex (Cotrimaxozole) 480mg Tab
₦500.00Add to cartCotrimoxazole, also known as trimethoprim/sulfamethoxazole, is a fixed-dose combination antibiotic medication. It consists of a mixture of two components: sulfamethoxazole and trimethoprim, in the proportions of 5 to 1. These components work synergistically to produce a bactericidal or bacteriostatic action against a wide range of gram-positive and gram-negative organisms as well as some protozoa. Additionally, cotrimoxazole is active against Pneumocystis carinii, a common opportunistic pathogen in immunocompromised individuals.
Reviews
There are no reviews yet.